Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum

Abstract

This study suggests that low-dose sirolimus can modestly reduce overgrowth, but cautions that the side-effect profile is significant, mandating individualized risk-benefit evaluations for sirolimus treatment in PROS.